top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

50.60 UNCHANGED
Delayed Quote Updated: 7:00 PM EST, Nov 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
News headline image
GSK Accelerates Late-Stage Studies as It Targets COPD and Long-Acting Respiratory Treatments ↗
GSK (NYSE:GSK) is advancing a portfolio of long-acting medicines and combination treatments for respiratory and inflammatory diseases, with a particular focus on chronic obstructive pulmonary disease,... 
Via MarketBeat
Topics Intellectual Property
News headline image
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine
Alamar’s NULISAseq™ Immune 340 and NULISAseq™ Neuro 220 panels will be used to investigate disease progression, biological subtypes and treatment response 
From Alamar Biosciences, Inc.
Via GlobeNewswire
News headline image
GSK (GSK) Q3 2026 Earnings Call Transcript ↗
Specialty medicines surged 15% as oncology and respiratory treatments drove growth. 
Via The Motley Fool
Topics Earnings Economy
GSK PLC-SPON ADR (NYSE:GSK) Passes Quality-Focused Caviar Cruise Stock Screener with Strong Profitability and Cash Flow ↗
Via Chartmill
News headline image
What GSK (GSK) Said on Its Q3 Earnings Call ↗
GSK (NYSE:GSK) reported third-quarter sales growth of 5% at constant exchange rates to £8.9 billion, supported by specialty medicines, new product launches and oncology growth. Core operating profit... 
Via MarketBeat
Topics Earnings Intellectual Property
News headline image
GSK Showcases Strong Oncology Pipeline Data at ESMO Investor Update ↗
GSK (NYSE:GSK) highlighted clinical data across its oncology pipeline at the European Society for Medical Oncology meeting, including updates for its B7-H3 antibody-drug conjugate ris-rez, B7-H4 ADC... 
Via MarketBeat
Topics Intellectual Property
News headline image
Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)
From GSK plc
Via Business Wire
News headline image
Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
From GSK plc
Via Business Wire
News headline image
Prediction: These 3 Dividend Stocks Will Raise Their Payouts No Matter What the Market Does ↗
These three dividend stocks sell products people buy out of necessity rather than by choice, making their next payout increase feel less like hope and more like a certainty. 
Via The Motley Fool
Topics Economy
News headline image
GSK Bets on Long-Acting Biologics and AI to Reshape Respiratory Care ↗
GSK (NYSE:GSK) is advancing a respiratory and immunology pipeline centered on longer-acting biologics, more targeted patient selection and combination approaches, according to Kaivan Khavandi, the... 
Via MarketBeat
Topics Artificial Intelligence Intellectual Property
News headline image
GSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take Shape ↗
GSK (NYSE:GSK) Chief Financial Officer Julie Brown outlined the company’s growth strategy, launch priorities and cost-savings plans during a discussion with Bank of America analyst Sachin Jain... 
Via MarketBeat
Topics Economy Intellectual Property
News headline image
GSK Targets Oncology Growth With Lung, Prostate and Gynecologic Cancer Pipeline ↗
GSK (NYSE:GSK) is pursuing a focused oncology expansion built around hematologic malignancies, gynecologic cancers, lung cancer, gastrointestinal cancers and prostate cancer, with a combination of... 
Via MarketBeat
Topics Intellectual Property
News headline image
GSK Targets £1.9B Savings to Fuel Pipeline, Navigate HIV Patent Cliff ↗
GSK (NYSE:GSK) is accelerating investment in research and development, expanding its late-stage pipeline and targeting cost savings to support product launches while maintaining profitability through... 
Via MarketBeat
Topics Artificial Intelligence Intellectual Property
News headline image
Gibson Energy (GEI) Q2 2026 Earnings Call Transcript ↗
Record infrastructure EBITDA and improved marketing guidance signal strong momentum. 
Via The Motley Fool
Topics Earnings
News headline image
GSK Q2 Earnings Call Highlights ↗
GSK (NYSE:GSK) reported second-quarter sales growth of 5% at constant exchange rates to more than £8.4 billion, supported by Specialty Medicines and Vaccines, while outlining a new cost-savings and... 
Via MarketBeat
Topics Earnings Intellectual Property
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Core Restore Founder Ann Peets Announces Bladder Leak Treatments In Charleston
Via Press Release Distribution Service
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
Via Investor Brand Network
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Arcosa, Inc. (NYSE – ACA), Fathom Holdings Inc. (Nasdaq – FTHM), Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
From BioMedWire
Via GlobeNewswire
News headline image
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
From GSK plc
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN), SUNation Energy, Inc. (Nasdaq – SUNE), Taylor Morrison Home Corporation (NYSE - TMHC)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
MarketBeat Week in Review – 06/08 - 06/12 ↗
Stocks rallied on optimism surrounding a potential U.S.-Iran peace deal and SpaceX's historic IPO debut, reinforcing investor confidence and market momentum 
Via MarketBeat
Topics Economy Initial Public Offering
News headline image
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion ↗
GSK agreed to acquire Nuvalent for $10.6 billion, or $124 per share, a roughly 40% premium, to add two late-stage lung cancer assets and offset an impending patent cliff. 
Via MarketBeat
Topics Intellectual Property
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), SUNation Energy, Inc. (Nasdaq – SUNE), Organon & Co. (NYSE – OGN), Taylor Morrison Home Corporation (NYSE – TMHC)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More ↗
Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements in the global healthcare market. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Income Fund Just Completely Exited Its $37 Million Stake in Algonquin Power. Why? ↗
Algonquin serves approximately 1.3 million customer connections across the United States, Canada, Bermuda, and Chile through its regulated utility network. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults
From GSK plc
Via Business Wire
News headline image
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat ↗
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page